Exposure to second-hand smoke and breast cancer risk in non-smoking women: a comprehensive systematic review and meta-analysis.


Journal

British journal of cancer
ISSN: 1532-1827
Titre abrégé: Br J Cancer
Pays: England
ID NLM: 0370635

Informations de publication

Date de publication:
28 Jun 2024
Historique:
received: 18 04 2023
accepted: 20 05 2024
revised: 16 05 2024
medline: 29 6 2024
pubmed: 29 6 2024
entrez: 28 6 2024
Statut: aheadofprint

Résumé

Through the use of an innovative method to identify original publications, we conducted a meta-analysis of all epidemiological studies evaluating the association between second-hand smoke (SHS) exposure and breast cancer risk among female non-smokers published in English up to October 2022. Pooled relative risks (RR) were obtained through the use of random-effects models. Dose-response relationships were derived using log-linear functions. Out of 73 identified eligible studies, 63 original articles were included in the meta-analysis. The pooled RR for breast cancer for overall exposure to SHS was 1.24 (95% confidence interval, CI, 1.15-1.34, number of articles, n = 52). Regarding the setting of exposure, RRs were 1.17 (95% CI 1.08-1.27, n = 37) for SHS exposure at home, 1.03 (95% CI 0.98-1.08, n = 15) at the workplace, 1.24 (95% CI 1.11-1.37, n = 16) at home or workplace, and 1.45 (95% CI 1.16-1.80, n = 13) for non-specified settings. The risk of breast cancer increased linearly with higher duration (RR 1.29; 95% CI 1.04-1.59 for 40 years of SHS exposure, n = 12), intensity (RR 1.38; 95% CI 1.14-1.67 for 20 cigarettes of SHS exposure per day, n = 6), and pack-years (RR 1.50; 95% CI 0.92-2.45 for 40 SHS pack-years, n = 6) of SHS exposure. This meta-analysis shows a statistically significant excess risk of breast cancer in women exposed to SHS.

Identifiants

pubmed: 38942988
doi: 10.1038/s41416-024-02732-5
pii: 10.1038/s41416-024-02732-5
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research)
ID : 25840
Organisme : Regione Toscana (Tuscany Region)
ID : 16906
Organisme : Regione Toscana (Tuscany Region)
ID : 16906

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer Nature Limited.

Références

Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Pineros M, Znaor A, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021. https://doi.org/10.1002/ijc.33588
doi: 10.1002/ijc.33588 pubmed: 34460109
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.
doi: 10.3322/caac.21660 pubmed: 33538338
Boffetta P, La Vecchia C Neoplasms. In: Detels R, Beaglehole R, Lansang M, editors. Oxford textbook of public health 5th edition. New York: Oxford University Press; 2009. pp. 997–1020.
Collaborative Group on Hormonal Factors in Breast Cancer. Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol. 2012;13:1141–51.
doi: 10.1016/S1470-2045(12)70425-4 pmcid: 3488186
Ewertz M, Duffy SW, Adami HO, Kvåle G, Lund E, Meirik O, et al. Age at first birth, parity and risk of breast cancer: a meta-analysis of 8 studies from the Nordic countries. Int J Cancer. 1990;46:597–603.
doi: 10.1002/ijc.2910460408 pubmed: 2145231
Bagnardi V, Rota M, Botteri E, Tramacere I, Islami F, Fedirko V, et al. Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis. Br J Cancer. 2015;112:580–93.
doi: 10.1038/bjc.2014.579 pubmed: 25422909
Hamajima N, Hirose K, Tajima K, Rohan T, Calle EE, Heath CW Jr., et al. Alcohol, tobacco and breast cancer—collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer. 2002;87:1234–45.
doi: 10.1038/sj.bjc.6600596 pubmed: 12439712
Steindorf K, Ritte R, Eomois PP, Lukanova A, Tjonneland A, Johnsen NF, et al. Physical activity and risk of breast cancer overall and by hormone receptor status: the European prospective investigation into cancer and nutrition. Int J Cancer. 2013;132:1667–78.
doi: 10.1002/ijc.27778 pubmed: 22903273
Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D, et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ. 2007;335:1134.
doi: 10.1136/bmj.39367.495995.AE pubmed: 17986716 pmcid: 2099519
Chlebowski RT, Manson JE, Anderson GL, Cauley JA, Aragaki AK, Stefanick ML, et al. Estrogen plus progestin and breast cancer incidence and mortality in the Women’s Health Initiative Observational Study. J Natl Cancer Inst. 2013;105:526–35.
doi: 10.1093/jnci/djt043 pubmed: 23543779 pmcid: 3691942
Morch LS, Hannaford PC, Lidegaard O. Contemporary hormonal contraception and the risk of breast cancer. New Engl J Med. 2018;378:1265–6.
pubmed: 29590551
IARC. Personal habits and indoor combustions. IARC Monogr Eval Carcinog Risks Hum. 2012;100 E:1–538.
Scala M, Bosetti C, Bagnardi V, Possenti I, Specchia C, Gallus S, et al. Dose-response relationships between cigarette smoking and breast cancer risk: a systematic review and meta-analysis. J Epidemiol. 2023;33:640–8.
doi: 10.2188/jea.JE20220206 pubmed: 36967121 pmcid: 10635814
Miller MD, Marty MA, Broadwin R, Johnson KC, Salmon AG, Winder B, et al. California Environmental Protection Agency. The association between exposure to environmental tobacco smoke and breast cancer: a review by the California Environmental Protection Agency. Prev Med. 2007;44:93–106.
World Health Organization. WHO report on the global tobacco epidemic, 2015: raising taxes on tobacco. Geneva, Switzerland: World Health Organization; 2015. Available at https://www.who.int/publications/i/item/9789241509121 (Accessed 27 June 2024).
U.S. Department of Health and Human Services. The health consequences of smoking — 50 years of progress. A report of the surgeon general. Rockville, MD: Public Health Service, Office of the Surgeon General; 2014.
Thompson PA, DeMarini DM, Kadlubar FF, McClure GY, Brooks LR, Green BL, et al. Evidence for the presence of mutagenic arylamines in human breast milk and DNA adducts in exfoliated breast ductal epithelial cells. Environ Mol Mutagen. 2002;39:134–42.
doi: 10.1002/em.10067 pubmed: 11921181
Collishaw NE, Boyd NF, Cantor KP, Hammond SK, Johnson KC, Millar J, et al. Canadian expert panel on tobacco smoke and breast cancer risk. Toronto: Ontario Tobacco Research Unit; 2009.
IARC. Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum. 2004;83:1–1438.
He Y, Si Y, Li X, Hong J, Yu C, He N. The relationship between tobacco and breast cancer incidence: a systematic review and meta-analysis of observational studies. Front Oncol. 2022;12:961970.
doi: 10.3389/fonc.2022.961970 pubmed: 36185316 pmcid: 9520920
Kim AS, Ko HJ, Kwon JH, Lee JM. Exposure to secondhand smoke and risk of cancer in never smokers: a meta-analysis of epidemiologic studies. Int J Environ Res public health. 2018;15:1981.
doi: 10.3390/ijerph15091981 pubmed: 30208628 pmcid: 6164459
Lee PN, Hamling JS. Environmental tobacco smoke exposure and risk of breast cancer in nonsmoking women. An updated review and meta-analysis. Inhalation Toxicol. 2016;28:431–54.
doi: 10.1080/08958378.2016.1210701
Lugo A, Bosetti C, Peveri G, Rota M, Bagnardi V, Gallus S. Dose-response relationship between cigarette smoking and site-specific cancer risk: protocol for a systematic review with an original design combining umbrella and traditional reviews. BMJ Open. 2017;7:e018930.
doi: 10.1136/bmjopen-2017-018930 pubmed: 29092902 pmcid: 5695313
Botteri E, Borroni E, Sloan EK, Bagnardi V, Bosetti C, Peveri G, et al. Smoking and colorectal cancer risk, overall and by molecular subtypes: a meta-analysis. Am J Gastroenterol. 2020;115:1940–9.
doi: 10.14309/ajg.0000000000000803 pubmed: 32773458
Lugo A, Peveri G, Bosetti C, Bagnardi V, Crippa A, Orsini N, et al. Strong excess risk of pancreatic cancer for low frequency and duration of cigarette smoking: a comprehensive review and meta-analysis. Eur J Cancer. 2018;104:117–26.
doi: 10.1016/j.ejca.2018.09.007 pubmed: 30347287
Malevolti MC, Lugo A, Scala M, Gallus S, Gorini G, Lachi A, et al. Dose-risk relationships between cigarette smoking and cervical cancer: a systematic review and meta-analysis. Eur J Cancer Prev. 2022;32:171–83.
Santucci C, Bosetti C, Peveri G, Liu X, Bagnardi V, Specchia C, et al. Dose-risk relationships between cigarette smoking and ovarian cancer histotypes: a comprehensive meta-analysis. Cancer Causes Control. 2019;30:1023–32.
doi: 10.1007/s10552-019-01198-8 pubmed: 31236793
Rota M, Possenti I, Valsassina V, Santucci C, Bagnardi V, Corrao G, et al. Dose–response association between cigarette smoking and gastric cancer risk: a systematic review and meta-analysis Gastric Cancer. 2024;27:1–13.
Hamling J, Lee P, Weitkunat R, Ambuhl M. Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Stat Med. 2008;27:954–70.
doi: 10.1002/sim.3013 pubmed: 17676579
Rucker G, Cates CJ, Schwarzer G. Methods for including information from multi-arm trials in pairwise meta-analysis. Res Synth Methods. 2017;8:392–403.
doi: 10.1002/jrsm.1259 pubmed: 28759708
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.
doi: 10.1016/0197-2456(86)90046-2 pubmed: 3802833
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.
doi: 10.1002/sim.1186 pubmed: 12111919
Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol. 2008;61:991–6.
doi: 10.1016/j.jclinepi.2007.11.010 pubmed: 18538991
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629–34.
doi: 10.1136/bmj.315.7109.629 pubmed: 9310563 pmcid: 2127453
Balduzzi S, Rucker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22:153–60.
doi: 10.1136/ebmental-2019-300117 pubmed: 31563865 pmcid: 10231495
Crippa AON. Multivariate dose-response meta-analysis: the dosresmeta R package. J Stat Softw. 2016;72:1–15.
Wells AJ. Re: “Breast cancer, cigarette smoking, and passive smoking”. Am J Epidemiol. 1998;147:991–2.
doi: 10.1093/oxfordjournals.aje.a009390 pubmed: 9596478
WHO. Alcohol is one of the biggest risk factors for breast cancer. Available at: https://www.who.int/europe/news/item/20-10-2021-alcohol-is-one-of-the-biggest-risk-factors-for-breast-cancer (Accessed 3 March 2023). 2021.
Oberg M, Jaakkola MS, Woodward A, Peruga A, Pruss-Ustun A. Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries. Lancet. 2011;377:139–46.
doi: 10.1016/S0140-6736(10)61388-8 pubmed: 21112082
GBD 2016 Alcohol Collaborators. Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2018;392:1015–35.
Dossus L, Boutron-Ruault MC, Kaaks R, Gram IT, Vilier A, Fervers B, et al. Active and passive cigarette smoking and breast cancer risk: results from the EPIC cohort. Int J Cancer. 2014;134:1871–88.
doi: 10.1002/ijc.28508 pubmed: 24590452
Reynolds P. Smoking and breast cancer. J Mammary Gland Biol Neoplasia. 2013;18:15–23.
doi: 10.1007/s10911-012-9269-x pubmed: 23179580
Shrubsole MJ, Gao YT, Dai Q, Shu XO, Ruan ZX, Jin F, et al. Passive smoking and breast cancer risk among non-smoking Chinese women. Int J Cancer. 2004;110:605–9.
doi: 10.1002/ijc.20168 pubmed: 15122595
Johnson KC, Wells AJ. Active and passive smoking in breast cancer. Epidemiology. 2002;13:745–6.
doi: 10.1097/00001648-200211000-00027 pubmed: 12410024
Rothman KJ, Greenland S. Modern epidemiology. 2nd edn. Philadelphia: Lippincott-Raven; 1998.
Chang-Claude J, Kropp S, Jager B, Bartsch H, Risch A. Differential effect of NAT2 on the association between active and passive smoke exposure and breast cancer risk. Cancer Epidemiol Biomark Prev. 2002;11:698–704.
Millikan RC, Pittman GS, Newman B, Tse CK, Selmin O, Rockhill B, et al. Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol Biomark Prev. 1998;7:371–8.
Tang H, Yang D, Han C, Mu P. Smoking, DNA methylation, and breast cancer: a Mendelian randomization study. Front Oncol. 2021;11:745918.
doi: 10.3389/fonc.2021.745918 pubmed: 34650928 pmcid: 8507148
Gram IT, Wiik AB, Lund E, Licaj I, Braaten T. Never-smokers and the fraction of breast cancer attributable to second-hand smoke from parents during childhood: the Norwegian Women and Cancer Study 1991-2018. Int J Epidemiol. 2022;50:1927–35.
doi: 10.1093/ije/dyab153 pubmed: 34999865
Morabia A, Bernstein M, Ruiz J, Heritier S, Diebold Berger S, Borisch B. Relation of smoking to breast cancer by estrogen receptor status. Int J Cancer. 1998;75:339–42.
doi: 10.1002/(SICI)1097-0215(19980130)75:3<339::AID-IJC2>3.0.CO;2-3 pubmed: 9455790
Strumylaite L, Kregzdyte R, Poskiene L, Bogusevicius A, Pranys D, Norkute R. Association between lifetime exposure to passive smoking and risk of breast cancer subtypes defined by hormone receptor status among non-smoking Caucasian women. PLoS ONE. 2017;12:e0171198.
doi: 10.1371/journal.pone.0171198 pubmed: 28151962 pmcid: 5289535
U.S. Department of Health and Human Services. The health consequences of involuntary exposure to tobacco smoke: a report of the surgeon general. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2006.
Zeng X, Zhang Y, Kwong JS, Zhang C, Li S, Sun F, et al. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med. 2015;8:2–10.
doi: 10.1111/jebm.12141 pubmed: 25594108
Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295–300.
pubmed: 14283879 pmcid: 1898525

Auteurs

Irene Possenti (I)

Department of Medical Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Marco Scala (M)

Department of Medical Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Giulia Carreras (G)

Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.

Vincenzo Bagnardi (V)

Department of Statistics and Quantitative Methods, Università degli Studi di Milano-Bicocca, Milan, Italy.

Cristina Bosetti (C)

Department of Medical Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Giuseppe Gorini (G)

Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.

Caterina Maci (C)

Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.

Maria Chiara Malevolti (MC)

Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.

Anna Odone (A)

Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy.

Luc Smits (L)

Faculty Health, Medicine and Life Sciences, Department of Epidemiology, Maastricht University, Maastricht, The Netherlands.

Claudia Specchia (C)

Department of Molecular and Translational Medicine, Università degli Studi di Brescia, Brescia, Italy.

Silvano Gallus (S)

Department of Medical Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Alessandra Lugo (A)

Department of Medical Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy. alessandra.lugo@marionegri.it.

Classifications MeSH